MacroGenics | MGNX - Umsatzkosten





Umsatzkosten Veränderung Datum
AbbVie USD 4.22B 329M 2026-03
Amgen USD 1.6B 187M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Biogen USD 797.5M 302M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Genmab DKK 81M 23M 2025-12
Geron USD 1.69M 386K 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
J&J USD 8.07B 103M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Merck USD 2.94B 380M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Xencor USD 61.66M 50.95M 2025-06